Drug Administration Routes
"Drug Administration Routes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue.
| Descriptor ID |
D004333
|
| MeSH Number(s) |
E02.319.267
|
| Concept/Terms |
Drug Administration Routes- Drug Administration Routes
- Administration Routes, Drug
- Administration Route, Drug
- Drug Administration Route
- Route, Drug Administration
- Routes, Drug Administration
|
Below are MeSH descriptors whose meaning is more general than "Drug Administration Routes".
Below are MeSH descriptors whose meaning is more specific than "Drug Administration Routes".
This graph shows the total number of publications written about "Drug Administration Routes" by people in this website by year, and whether "Drug Administration Routes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 9 | 9 |
| 2018 | 0 | 11 | 11 |
| 2019 | 0 | 3 | 3 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Administration Routes" by people in Profiles.
-
Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics. J Clin Pharmacol. 2021 08; 61(8):1096-1105.
-
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection. Curr Opin Virol. 2021 08; 49:36-40.
-
Vitamin C in the Treatment of COVID-19. Nutrients. 2021 Apr 01; 13(4).
-
Pharmacologic therapeutic options for thromboprophylaxis in COVID-19. J Thromb Thrombolysis. 2021 Jan; 51(1):29-30.
-
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis (Lond). 2021 02; 53(2):102-110.
-
Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19. Semin Thromb Hemost. 2020 10; 46(7):789-795.
-
Diabetes care during the acute phase of infection in ICU patients with specific attention to COVID-19 outbreak. Anaesth Crit Care Pain Med. 2020 06; 39(3):375-379.
-
Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey. BMJ Support Palliat Care. 2020 Sep; 10(3):343-349.
-
Pharmaceutical care in hospitalized patients. (Management of the COVID-19 pandemic crisis. A new challenge for pharmacy services). Farm Hosp. 2020 06 12; 44(7):28-31.
-
Hospital Pharmacy Compounding against COVID-19 pandemic. Farm Hosp. 2020 06 12; 44(7):49-52.